Skip to main content
OpenTrials

Clinical trial condition

Sweat Gland Diseases

Explore clinical trials studying Sweat Gland Diseases. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Sweat Gland Diseases trial results

Enrolling by Invitation

A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07007637

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Birmingham, Alabama, United States
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Los Angeles, California, United States
  • Clinical Site Northridge, California, United States
View all 166 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06411379

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Birmingham, Alabama, United States
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Fountain Valley, California, United States
  • Clinical Site Santa Monica, California, United States
View all 106 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06411899

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site Los Angeles, California, United States
  • Clinical Site Northridge, California, United States
  • Clinical Site Sacramento, California, United States
  • Clinical Site San Diego, California, United States
View all 109 locations
View Trial Details
Completed

Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

NCT05322473

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Folliculitis, +13 more
Locations
  • Clinical Site Fountain Valley, California, United States
  • Clinical Site Los Angeles, California, United States
  • Clinical Site Miami, Florida, United States
  • Clinical Site Ormond Beach, Florida, United States
View all 57 locations
View Trial Details
Active, Not Recruiting

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

NCT06993610

Conditions
Acne Vulgaris, Acneiform Eruptions, Bacterial Infections, +13 more
Locations
  • Medical Dermatology Specialists (Phoenix) Phoenix, Arizona, United States
  • First OC Dermatology Research, Inc. Irvine, California, United States
  • Wallace Medical Group, Inc. Los Angeles, California, United States
  • Northridge Clinical Trials Northridge, California, United States
View all 61 locations
View Trial Details
Active, Not Recruiting

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

NCT06768671

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
Locations
  • Clinical Site North Little Rock, Arkansas, United States
  • Clinical Site Stanford, California, United States
  • Clinical Site Washington D.C., District of Columbia, United States
  • Clinical Site Hollywood, Florida, United States
View all 18 locations
View Trial Details

Related conditions